GLP-1 Weight Loss Blog

GLP-1 medications don't just cause weight loss — they have direct cardiovascular benefits backed by major clinical trials. Here's what the research shows.

Tirzepatide is powerful on its own — but the right strategies can significantly amplify your results. Here's how to get the most out of your program.

Ozempic and Wegovy both contain semaglutide but are approved for different uses at different doses. Here's the key difference and which one is right for weight loss.

GLP-1 medications have specific FDA eligibility criteria. Here's exactly who qualifies, what conditions count, and what disqualifies patients from treatment.

Research consistently shows telehealth weight loss programs produce outcomes comparable to in-person care — often with better adherence due to convenience.

Nausea is the most common side effect of semaglutide, but it's manageable. Here's why it happens and the most effective ways to reduce it.

Long-term GLP-1 weight loss is achievable — but it requires a thoughtful maintenance strategy. Here's what the research shows about sustained results.

Stopping semaglutide without a maintenance plan typically leads to weight regain. Here's what the research shows and how to plan for long-term success.

Most patients notice tirzepatide working within the first 1-2 weeks. Here's the full timeline from first dose to peak results, based on clinical data.

Semaglutide offers dual benefits for prediabetic patients: significant weight loss and meaningful improvements in blood sugar and insulin sensitivity.